跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levox - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levox
Approved
STANDARD
Levox
Amherst Parenterals, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
118ef6f5aaa91696
Company
Amherst Parenterals, Inc.
Type
Standard
Approval Details
Approval Id
118ef6f5aaa91696
Drug Approval Philippines Name
Levox
Product Name
Levox
Registration Number
DR-XY27919
Brand Name
Levox
Generic Name
Levofloxacin (As Hemihydrate)
Dosage Form
Solution For Infusion (Iv)
Dosage Strength
5 mg/mL (500 mg/100 mL)
Manufacturer
Amherst Parenterals, Inc.
Trader
UNILAB, Inc.
Issuance Date
24 June 2022
Expiry Date
13 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
118ef6f5aaa91696
Type
Standard
Back to Philippines FDA Approvals